Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-2-7
pubmed:abstractText
Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high-grade histology, aggressive clinical behavior, and poor survival. It has been determined that breast cancers that are negative for ER and PR but positive for HER2 (double negative [DN]) share features with TN breast cancers. In this report, the authors quantified the contribution of HER2 as well as demographic and tumor characteristics to the survival of women with TN tumors, DN tumors, and other breast cancers (OBC).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
Cancer 2008. (c) 2008 American Cancer Society.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
112
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
737-47
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18189290-African Americans, pubmed-meshheading:18189290-Algorithms, pubmed-meshheading:18189290-Asian Americans, pubmed-meshheading:18189290-Breast Neoplasms, pubmed-meshheading:18189290-California, pubmed-meshheading:18189290-Female, pubmed-meshheading:18189290-Hispanic Americans, pubmed-meshheading:18189290-Humans, pubmed-meshheading:18189290-Middle Aged, pubmed-meshheading:18189290-Neoplasm Invasiveness, pubmed-meshheading:18189290-Neoplasm Staging, pubmed-meshheading:18189290-Receptor, erbB-2, pubmed-meshheading:18189290-Receptors, Estrogen, pubmed-meshheading:18189290-Receptors, Progesterone, pubmed-meshheading:18189290-Registries, pubmed-meshheading:18189290-Regression Analysis, pubmed-meshheading:18189290-Social Class, pubmed-meshheading:18189290-Survival Analysis
pubmed:year
2008
pubmed:articleTitle
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
pubmed:affiliation
Public Health Institute/Cancer Surveillance Program, Sacramento, California 95818, USA. mbrown@ccr.ca.gov
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural